Nicholas M. Dean
Keine laufenden Positionen mehr
Profil
Dr. Nicholas M.
Dean is a Director & Chief Scientific Officer at Microlin Bio, Inc. He is on the Board of Directors at Microlin Bio, Inc.
Dr. Dean was previously employed as a Director & Chief Scientific Officer by Excaliard Pharmaceuticals, Inc. and Vice President-Functional Genomics & Oncology by Isis Pharmaceuticals, Inc.
He received his undergraduate degree from The University of Wales and a doctorate degree from The University of Wales.
Ehemalige bekannte Positionen von Nicholas M. Dean
Unternehmen | Position | Ende |
---|---|---|
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Gründer | 01.03.2012 |
Microlin Bio, Inc. /Old/
Microlin Bio, Inc. /Old/ Medical SpecialtiesHealth Technology Microlin Bio, Inc. is a pre-clinical stage biopharmaceutical company. It focuses on the development of miR-based diagnostics and therapeutics, including both antimiRs and miR mimics, to diagnose and treat cancer. The company was founded by Joseph Hernandez on July 30, 2013 and is headquartered in New York, NY. | Technik-/Wissenschafts-/F&E-Leiter | - |
IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Nicholas M. Dean
The University of Wales | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
IONIS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Excaliard Pharmaceuticals, Inc.
Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Health Technology |
Microlin Bio, Inc. /Old/
Microlin Bio, Inc. /Old/ Medical SpecialtiesHealth Technology Microlin Bio, Inc. is a pre-clinical stage biopharmaceutical company. It focuses on the development of miR-based diagnostics and therapeutics, including both antimiRs and miR mimics, to diagnose and treat cancer. The company was founded by Joseph Hernandez on July 30, 2013 and is headquartered in New York, NY. | Health Technology |